THORATEC CORPORATION
Manufacturer adverse-event records for THORATEC CORPORATION come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.
FDA MAUDE device safety record · 2001–2026 · heavy-book · elevated Death-code · balanced
Death-code intensity
THORATEC CORPORATION carries an elevated Death-code share
Death-coded event_type rows are 14,279 of 70,427 (20.27% · elevated tercile among 434 manufacturers). Absolute volume is heavy-book.
What the Death-code reading shows for THORATEC CORPORATION
The standout signal for THORATEC CORPORATION is Death-code intensity: 20.27% of 70,427 reports (elevated tercile), while absolute volume is heavy-book.
As a heavy-book manufacturer, portfolio size and reporting obligations inflate absolute counts - pair THORATEC CORPORATION with device-family pages before treating company totals as a safety verdict. Event_type Death and Injury are one code per report; Patient Outcomes below use a separate FDA population.
Reports span 16 device types, led in this extract by Injury at 32,438 (46.1% of event_type total). Peak single-year volume reaches 8,139 reports across 26 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.
Event Types
Patient Outcomes
FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.
Devices (16)
Yearly Trend
Read our methodology - how this data is sourced, computed, and verified.